G8873 HCPCS Level II code: Patients with needle localization specimens which are not amenable to intraoperative imaging such as mri needle wire localization, or targets which are…
CMS terminated G8873: its last date of service was Dec 31, 2020. It stays here for looking up older claims; newer services need a current code.
Official description
G8873Patients with needle localization specimens which are not amenable to intraoperative imaging such as mri needle wire localization, or targets which are tentatively identified on mammogram or ultrasound which do not contain a biopsy marker but which can be verified on intraoperative inspection or pathology (e.g., needle biopsy site where the biopsy marker is remote from the actual biopsy site)
Short description: Specimen not intraop image
HCPCS · United States
Medicare details
The indicators CMS publishes with G8873 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)
- Type of service
- Medical care
- BETOS category
- Specialist - psychiatry
- Added
- Jan 1, 2012
- Terminated after
- Dec 31, 2020
Where G8873 sits
- 1G codesProcedures and professional services
- 2Terminated G8873Patients with needle localization specimens which are not amenable to intraoperative imaging such as mri needle wire localization, or targets which are tentatively identified on mammogram or ultrasound which do not contain a biopsy marker but which can be verified on intraoperative inspection or pathology (e.g., needle biopsy site where the biopsy marker is remote from the actual biopsy site)
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
Is HCPCS code G8873 still valid?
No. CMS terminated G8873; its last date of service was Dec 31, 2020. It is listed for looking up services from before then. Use a current code for newer services.
Does Medicare cover G8873?
CMS lists G8873’s Medicare coverage as “Carrier judgment” and its pricing as “Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside G8873
All G codesG8867Pneumococcal vaccine not administered or previously received, reason not givenG8868Patients receiving a first course of anti-tnf therapyG8869Patient has documented immunity to hepatitis b and initiating anti-tnf therapyG8870Hepatitis b vaccine injection administered or previously received and is receiving a first course of anti-tnf therapyG8871Patient not receiving a first course of anti-tnf therapyG8872Excised tissue evaluated by imaging intraoperatively to confirm successful inclusion of targeted lesionG8874Excised tissue not evaluated by imaging intraoperatively to confirm successful inclusion of targeted lesionG8875Clinician diagnosed breast cancer preoperatively by a minimally invasive biopsy methodG8876Documentation of reason(s) for not performing minimally invasive biopsy to diagnose breast cancer preoperatively (e.g., lesion too close to skin, implant, chest wall, etc.…G8877Clinician did not attempt to achieve the diagnosis of breast cancer preoperatively by a minimally invasive biopsy method, reason not givenG8878Sentinel lymph node biopsy procedure performedG8879Clinically node negative (t1n0m0 or t2n0m0) invasive breast cancer